NHLBI Catalyze
NHLBI Catalyze Program: Transforming basic scientific discoveries into viable therapeutics, devices, and diagnostics to treat heart, lung, blood, and sleep diseases and disorders.
The mission of NHLBI Catalyze is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop a translational research workforce fluent in product development and entrepreneurship.
More information is available at the NHLBI Catalyze Public Website.
This research was, in part, funded by the National Institutes of Health (NIH) Agreement OT2 HL157844-01. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH.
Patent Protection of Biomedical Innovations
Funding your project from the perspective of an entrepreneur and investor
Applying to Catalyze: A program overview and review of the application process
Peer-to-Peer Learning: Catalyze Awardee Panel Presentation & Discussion
Preparing for Regulatory Filings: Information Needed for Chemistry, Manufacturing & Controls and Q&A
From target to translational funding: a journey from academic discovery to an investable therapeutic
Business Development Insights: Panel discussion with industry experts
Catalyze Annual Meeting 2024: Reimbursement 101 Training: Introductory Topics
Catalyze Annual Meeting 2024: Building a Commercialization Plan
Catalyze Annual Meeting 2024: How to Prepare for a Pre-IND and INTERACT Meeting (Breakout session)
Catalyze Annual Meeting 2024: Program Overview
Considerations for External Partnership: Chemistry, Manufacturing, and Controls
Don't Wait Until It's Too Late: Target Product Profiles and Avoiding Common Clinical Trial Mistakes
The Art of Market Sizing: Defining your Technology's Opportunity
Defining and Engaging Your End User (2023 Annual Meeting)
Protecting Your Technology: IP Strategy & Considerations (2023 Annual Meeting)
Engaging with FDA: Center for Devices and Radiological Health (2023 Annual Meeting)
Attracting Key Investors: Workshopping Your 90 Second Pitch (2023 Annual Meeting)
Catalyze Early Career Scientist Award Presentation (2023 Annual Meeting)
Developing Your Product’s Competitive Advantages (2023 Annual Meeting)
Discovering Diverse Sources of Follow-On Funding (2023 Annual Meeting)
Alternatives to Animal Testing: Leveraging the Modernization Act 2.0 (2023 Annual Meeting)
Exploring the Impact of Artificial Intelligence on Medical Product Development (2023 Annual Meeting)
Preparing for and Managing Contract Organizations in the Development of Medical Devices
Impacts of Artificial Intelligence on the Development of Medical Product
Early-Stage Design Control for Device Development
Catalyze Preclinical Services Program
Concept to Company: An Investigator's Guide to Starting a Business